TVRD
NASDAQ · Pharmaceuticals
Tvardi Therapeutics Inc
$1.87
+0.02 (+1.08%)
Open$1.87
Previous Close$1.85
Day High$1.94
Day Low$1.85
52W High$43.65
52W Low$1.50
Volume—
Avg Volume506.4K
Market Cap17.36M
P/E Ratio—
EPS$-1.60
SectorPharmaceuticals
Analyst Ratings
Buy
14 analysts
Price Target
+1,935.8% upside
Current
$1.87
$1.87
Target
$38.07
$38.07
$23.38
$38.07 avg
$43.34
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 42.64M | 62.98M | 10.81M |
| Net Income | -423,395,713 | -562,859,884 | 2.98M |
| Profit Margin | -993.0% | -943.3% | 27.6% |
| EBITDA | -390,900,973 | -548,531,646 | 3.89M |
| Free Cash Flow | — | — | 2.37M |
| Rev Growth | -32.3% | -32.3% | +19.2% |
| Debt/Equity | — | — | 0.91 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |